MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.athoracsur.2019.08.111

Медицинская библиотека · The Annals of thoracic surgery · 2019

Mitral Valve Replacement With a Third-Generation Porcine Valve: An Italian Multicentered Study.

Lorusso Roberto, Miceli Antonio, Gelsomino Sandro, Lio Antonio, Parise Orlando, Montisci Andrea, Vizzardi Enrico, Pacini Davide, Di Bartolomeo Roberto, Renzulli Attilio, Serraino Filiberto G, Comoglio Chiara, Liberi Roberta, Martinelli GianLuca, Sciangula Alfonso, Mazzola Alessandro, Faragalli Francesca, De Bonis Michele, Taramasso Maurizio, Alfieri Ottavio, Caimmi Philippe, Micalizzi Ezio, Mercogliano Domenico, Demicheli Gloria, Celiento Michele, Bortolotti Uberto, Solinas Marco, Glauber Mattia

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Postoperative outcomes of a third-generation porcine bioprosthesis for mitral valve replacement (MVR) have been poorly addressed. The objective of this study was to perform an independent, retrospective, multicenter study on outcomes of patients undergoing MVR with a Mosaic (Medtronic Inc, Minneapolis, MN) porcine bioprosthesis.

METHODS

From 1998 to 2011, 805 patients underwent MVR with a Mosaic porcine valve in 11 cardiac centers. There were 465 female patients (58%), and the overall mean age was 73.5 ± 7 years. Associated procedures included coronary artery bypass grafting (201 patients; 24.9%), aortic valve replacement (152 patients; 18.9%), tricuspid annuloplasty (187 patients; 22.3%), and other cardiac procedures (116 patients; 14.4%).

RESULTS

Median follow-up was 44 months (interquartile range, 16 to 63), with a cumulative duration of 2.769 patient-years. Early mortality for isolated elective MVR was 3.8% (12 of 313), and overall early mortality was 7.8% (n = 63). The rate of late mortality was 3.4%/patient-year (95 late deaths). At 10 years, overall survival was 57.4% (95% confidence interval [CI], 48.8% to 67.5%), and cumulative rates of cardiac- and valve-related death were 7.4% (95% CI, 4.8% to 10.1%) and 1.1% (95% CI, 0.2% to 1.9%), respectively. The 10-year cumulative rates of thromboembolic and hemorrhagic events were 6.6% (95% CI, 1.4% to 11.8%) and 3.9% (95% CI, 0.1% to 8%), respectively, and the 10-year cumulative incidence of prosthetic valve endocarditis was 3% (95% CI, 1.2% to 4.9%). Finally, the 10-year cumulative incidences of structural valve degeneration and reoperations were 5.8% (95% CI, 0.2% to 11.5%) and 4.8% (95% CI, 0.7% to 10.3%), respectively.

CONCLUSIONS

This independent, multicenter, retrospective study indicated that the Mosaic porcine bioprosthesis for MVR provides satisfactory results in terms of both early and long-term outcomes up to 14 years from its implantation.

Для цитирования: Lorusso Roberto, Miceli Antonio, Gelsomino Sandro, Lio Antonio, Parise Orlando, Montisci Andrea, Vizzardi Enrico, Pacini Davide, Di Bartolomeo Roberto, Renzulli Attilio, Serraino Filiberto G, Comoglio Chiara, Liberi Roberta, Martinelli GianLuca, Sciangula Alfonso, Mazzola Alessandro, Faragalli Francesca, De Bonis Michele, Taramasso Maurizio, Alfieri Ottavio, Caimmi Philippe, Micalizzi Ezio, Mercogliano Domenico, Demicheli Gloria, Celiento Michele, Bortolotti Uberto, Solinas Marco, Glauber Mattia. Mitral Valve Replacement With a Third-Generation Porcine Valve: An Italian Multicentered Study.. The Annals of thoracic surgery. 2019. DOI: 10.1016/j.athoracsur.2019.08.111.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.